Table 3.
Postoperative complications, length of treatment, and mortality rates
| Culture positive (n = 39) |
Culture negative (n = 200) |
P value | |
|---|---|---|---|
| Pleural effusion, n (%) | 35 (89.7) | 145 (72.5) | .025 |
| PCD, n (%) | 14 (35.9) | 35 (17.5) | .009 |
| Newly developed pulmonary consolidation, n (%) | 12 (30.8) | 36 (18.0) | .069 |
| Reintubation, n (%) | 4 (10.3) | 24 (12.0) | 1.000a |
| Infectious complications, n (%) | 1 (2.6) | 12 (6.0) | .700a |
| HLOS, days | 28.00 [21.50, 34.50] | 14.00 [10.00, 23.00] | < .001b |
| ICU LOS, days | 9.00 [4.00, 23.00] | 2.00 [1.00, 6.00] | .001b |
| Duration of antibiotics use, days | 11.00 [1.00, 26.00] | 8.00 [1.00, 15.75] | .073b |
| Duration of vasopressor use, days | 3.00 [2.00, 7.00] | 1.00 [0.00, 3.00] | .001b |
| MV day, days | 4.00 [1.00, 18.00] | 1.00 [0.00, 3.75] | < .001b |
| In-hospital mortality, n (%) | 14 (35.9) | 29 (14.5) | .001 |
| 30-day mortality, n (%) | 12 (30.8) | 24 (12.0) | .003 |
PCD percutaneous catheter drainage; HLOS hospital length of stay; ICU LOS intensive care unit length of stay; MV mechanical ventilator
aFisher’s exact test
bMann-Whitney U test